Marvell Lumentum Acquisition: $83 Billion AI Optics Deal?

Marvell Technology Inc. (NASDAQ: MARVL) is reportedly approaching one of the largest acquisitions in semiconductor history. According to Bloomberg's...

Salesforce Braze Acquisition: Why Pay A 58% Premium?

Salesforce (NYSE:CRM) is making another major acquisition, and this time, the target is customer engagement. The Salesforce Braze Acquisition...

SpaceX Tesla Merger: Starlink Profits, AI Spending & Valuation

SpaceX (NASDAQ: SPCX) is set to report its third-quarter results tonight, but the bigger story may extend well beyond...

Starbucks Chipotle Acquisition: Brian Niccol’s $50B Gamble?

Starbucks Corporation (NASDAQ:SBUX) could be considering one of the biggest acquisitions in restaurant industry history. Reports suggest the coffee...

Chipotle Acquisition Speculation: Who Wants to Buy It—Why Now?

Chipotle Mexican Grill (NYSE) has suddenly found itself at the center of Wall Street takeover chatter. Chipotle Acquisition Speculation...

Workday Silver Lake Buyout Talks Send Stock Up 18%

Workday (NASDAQ: WDAY) suddenly has a very different story on Wall Street. The Workday Silver Lake Buyout has quickly...

Rogers MLSE Acquisition Tests Sports Media Ambitions

Rogers Communications (NYSE:RCI) just moved closer to full control of one of Canada’s most valuable sports platforms. The company...

Novartis’ $1.5 Billion Myricx Deal Tests Oncology Pipeline

Novartis (NYSE:NVS) has made another clear move toward oncology depth, agreeing to acquire U.K.-based Myricx Bio for up to...

Kroger’s Giant Eagle Acquisition: Scale Or Risk?

Kroger (NYSE:KR) is back in the grocery consolidation spotlight after confirming plans to acquire family-owned Giant Eagle for $1.65...

Datadog Acquisition Of Adaptive ML Could Boost AI Growth

Datadog (NASDAQ:DDOG) just made a notable AI move. On June 30, 2026, the company announced a deal to acquire...

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

Merck KGaA (ETR:MRK) has made a bold early move under new CEO Kai Beckmann. The German drug, chemicals, and...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a...